TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
HCG Stock 12 Month Forecast
Average Price Target
₹737.00
▲(12.44% Upside)
Based on 2 Wall Street analysts offering 12 month price targets for HealthCare Global Enterprises Ltd. in the last 3 months. The average price target is ₹737.00 with a high forecast of ₹750.00 and a low forecast of ₹724.00. The average price target represents a 12.44% change from the last price of ₹655.45.
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.
HCG Analyst Recommendation Trends
Rating
Oct 25
Nov 25
Dec 25
Jan 26
Feb 26
Strong Buy
0
0
0
0
0
Buy
0
0
0
0
2
Hold
1
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
1
0
0
0
2
In the current month, HCG has received 2Buy Ratings, 0Hold Ratings, and 0Sell Ratings. HCG average Analyst price target in the past 3 months is 737.00.
Each month's total comprises the sum of three months' worth of ratings.
HCG Financial Forecast
HCG Earnings Forecast
Next quarter’s earnings estimate for HCG is ₹1.52 with a range of ₹1.52 to ₹1.52. The previous quarter’s EPS was ₹0.10. HCG beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year HCG has Performed in-line its overall industry.
Next quarter’s earnings estimate for HCG is ₹1.52 with a range of ₹1.52 to ₹1.52. The previous quarter’s EPS was ₹0.10. HCG beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year HCG has Performed in-line its overall industry.
HCG Sales Forecast
Next quarter’s sales forecast for HCG is ₹6.73B with a range of ₹6.73B to ₹6.73B. The previous quarter’s sales results were ₹6.31B. HCG beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year HCG has Performed in-line its overall industry.
Next quarter’s sales forecast for HCG is ₹6.73B with a range of ₹6.73B to ₹6.73B. The previous quarter’s sales results were ₹6.31B. HCG beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year HCG has Performed in-line its overall industry.
HCG Stock Forecast FAQ
What is IN:HCG’s average 12-month price target, according to analysts?
Based on analyst ratings, HealthCare Global Enterprises Ltd.’s 12-month average price target is 737.00.
What is IN:HCG’s upside potential, based on the analysts’ average price target?
HealthCare Global Enterprises Ltd. has 12.44% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is HealthCare Global Enterprises Ltd. a Buy, Sell or Hold?
HealthCare Global Enterprises Ltd. has a consensus rating of Moderate Buy, which is based on 2 buy ratings, 0 hold ratings and 0 sell ratings.
What is HealthCare Global Enterprises Ltd.’s share price target?
The average share price target for HealthCare Global Enterprises Ltd. is 737.00. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst share price target is ₹750.00 ,and the lowest forecast is ₹724.00. The average share price target represents 12.44% Increase from the current price of ₹655.45.
What do analysts say about HealthCare Global Enterprises Ltd.?
HealthCare Global Enterprises Ltd.’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Streets Analysts.
How can I buy shares of HealthCare Global Enterprises Ltd.?
To buy shares of IN:HCG, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.